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Protracted Protection to Plasmodium berghei Malaria Is
Linked to Functionally and Phenotypically Heterogeneous
Liver Memory CD8ⴙ T Cells1
Dmitri Berenzon,* Robert J. Schwenk,* Lisa Letellier,* Mimi Guebre-Xabier,2*
Jackie Williams,† and Urszula Krzych3*
We previously demonstrated that protection induced by radiation-attenuated (␥) Plasmodium berghei sporozoites is linked to
MHC class I-restricted CD8ⴙ T cells specific for exoerythrocytic-stage Ags, and that activated intrahepatic memory CD8ⴙ T cells
are associated with protracted protection. In this study, we further investigated intrahepatic memory CD8ⴙ T cells to elucidate mechanisms required for their maintenance. Using phenotypic markers indicative of activation (CD44, CD45RB), migration (CD62L), and
IFN-␥ production, we identified two subsets of intrahepatic memory CD8ⴙ T cells: the CD44highCD45RBlowCD62LlowCD122low phenotype, representing the dominant effector memory set, and the CD44highCD45RBhighCD62Llow/highCD122high phenotype, representing
the central memory set. Only the effector memory CD8ⴙ T cells responded swiftly to sporozoite challenge by producing sustained IFN-␥;
the central memory T cells responded with delay, and the IFN-␥ reactivity was short-lived. In addition, the subsets of liver memory
CD8ⴙ T cells segregated according to the expression of CD122 (IL-15R) in that only the central memory CD8ⴙ T cells were CD122high,
whereas the effector memory CD8ⴙ T cells were CD122low. Moreover, the effector memory CD8ⴙ T cells declined as protection waned
in mice treated with primaquine, a drug that interferes with the formation of liver-stage Ags. We propose that protracted protection
induced by P. berghei radiation-attenuated sporozoites depends in part on a network of interactive liver memory CD8ⴙ T cell subsets,
each representing a different phase of activation or differentiation, and the balance of which is profoundly affected by the repository of
liver-stage Ag and IL-15. The Journal of Immunology, 2003, 171: 2024 –2034.

T

he formation of optimally effective memory T cells is one
of the cardinal features of Ag-specifi immune responses
elicited by infections or vaccinations, and it is inextricably linked to long-lasting protective immunity. Memory T cells are
thought to arise either directly from naive populations or from
Ag-expanded effector cells that are spared apoptosis. However, the
mechanisms involved in the long-term maintenance of memory T
cells are less well defined Recent evidence suggests that maintenance of memory CD8⫹ and CD4⫹ T cells in peripheral immune
organs relies on mechanisms that are unique for each of the two T
cell sets. For example, although maintenance of memory CD8⫹ T
cells is independent of antigenic stimulation (1), the need for signaling through the TCR on memory CD4⫹ T cells is less clear (2).
The requirement for cytokines also differs between CD4⫹ and
CD8⫹ T cells; only memory CD8⫹ T cells require IL-15 (3), and
the presence of IL-4 during T cell activation has also been shown
to favor long-term survival of memory CD8⫹ T cells (4).
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Apart from memory T cells that reside in the spleen or lymph
nodes, we and others have shown that memory CD4⫹ and CD8⫹
T cells persist in nonlymphoid organs such as the liver (5), lungs
(6), and kidneys (7) following protozoan or viral infections. Unlike
memory T cells in peripheral lymphoid organs, the memory T cells
found in the nonlymphoid organs appear to express cell surface
markers characteristic of activated T cells (8). We have shown (9)
that radiation-attenuated Plasmodium berghei sporozoite (␥-spz)4immune intrahepatic mononuclear cells (IHMC), which adoptively
transfer lasting protective immunity to naive recipients, contain
CD4⫹ and CD8⫹ T cells that express a CD44high and CD45RBlow
phenotype. The kinetics of the expression of these surface markers
differs significantl between the two T cell subsets. In contrast to
CD4⫹CD45RBlow T cells that appear transiently following each
immunization with ␥-spz, the emergence of CD8⫹CD45RBlow coincides with the induction of protection, which in C57BL/6 mice
requires three weekly immunizations with ␥-spz. Significantly the
CD8⫹CD44highCD45RBlow T cell phenotype is still found in livers, but not spleens, of ␥-spz-immune mice 4 mo after challenge
with infectious spz. Therefore, it appears that the long-term protection induced by P. berghei ␥-spz is linked, at least in part, to the
persistence of activated memory CD8⫹ T cells in the liver (9). The
activated status of the memory cells that localize to the liver most
likely ensures a rapid reactivity to Plasmodium infection, hence a
very efficien effector function against the malaria parasite.
The liver is the key organ in malaria infection. It is the firs
organ targeted by plasmodia sporozoites (spz), because hepatocytes are an obligatory venue for schizogony, a process of plasmodia differentiation associated with amplificatio and molecular
4
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changes that result in an acquisition of novel Ags and increased Ag
load. Intrahepatic lymphocytes and Kupffer cells (10 –12) also render the liver a critical organ for the host’s defense. Protection in
naturally exposed persons has been directly linked with liver-stage
Ag (LSA)-specif c immune responses (13). For example, LSAspecif c T cells have been shown to be associated with both reduced incidence of severe malaria (14) as well as resistance to
Plasmodium falciparum (15) in naturally exposed persons. Hence,
the liver is considered not only pivotal for the survival of the
parasite but also as a crucial organ for the induction of antiPlasmodium protective immune responses.
In contrast to natural infection characterized by a slow acquisition of nonsterile protective immunity that wanes when exposure
to the parasite ceases, immunization of humans (16) and laboratory
rodents (17) with multiple doses of ␥-spz leads to a sterile and
lasting protection. It is believed that radiation partially retards the
development of the parasite (18, 19), so that the underdeveloped or
blocked liver schizonts unable to infect RBCs remain in the liver,
a step that is considered critical for the induction of a local Agspecif c protective immunity (20). Findings by Scheller and Azad
(21) support the notion that, indeed, LSAs are required for protracted protection. By extension, we propose that the persistence of
memory T cells in the liver, which appears essential for the longlived protection induced by ␥-spz, requires the presence of LSA.
The location of memory T cell pools is particularly crucial for the
prophylactic potential of memory T cell responses during re-encounter with a pathogen. Hence, the importance of organ- or tissue-specif c memory T cells cannot be overstated, because it is one
of the key elements for consideration in the planning and development of vaccines to prevent or abate infectious diseases.
In this study, we asked how P. berghei ␥-spz-induced memory
CD8⫹ T cells are maintained in the liver. We approached our
analyses by further characterization of liver memory T cells on the
basis of their phenotype and functional activity. In this study, we
show that the liver memory CD8⫹ T cell pool consists of at least
two subsets, each performing a unique function and displaying
somewhat different maintenance requirements. On the basis of
these observations, we propose that liver memory CD8⫹ T cells
form a network of interactive T cell sets, each representing a different phase of activation or differentiation, the balance of which is
profoundly affected by the local availability of specif c Ags as well
as the cytokine milieu.
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mediately after dissection to ensure maximal infectivity. Sham-dissected
salivary gland preparations obtained from noninfected mosquitoes were
attenuated and treated according to the same procedure as described
for spz.

Immunization
Mice were primed i.v. with 75,000 ␥-spz followed by two boost immunizations of 20,000 ␥-spz given 1 wk apart. Control mice were given three
i.v. injections 1 wk apart of medium alone. One week after the last immunization, mice were challenged i.v. with 10,000 infectious spz. When warranted, mice were rechallenged 6 or 10 mo after the f rst challenge. For
controls, mice were immunized three times with ␥-irradiated preparations
of sham-dissected salivary gland debris from noninfected mosquitoes. The
number of salivary glands for dissection was estimated on the basis of an
average number of spz yields per 10 mosquitoes.

Determination of parasitemia
Thin blood smears were prepared from individual mice starting on days
2– 4 postchallenge, and parasitemia was determined microscopically using
Giemsa stain, as described previously (5). Up to 40 oil-immersion f elds
were screened for the presence of parasitized erythrocytes. Mice were considered protected if parasites were not detected by day 14 after challenge.
Nonimmunized mice infected with P. berghei spz usually became parasitemic by day 7 and died by day 20 after challenge.

Primaquine treatment
Mice received 60 mg/kg body weight of primaquine phosphate (a gift from
W. Ellis, Walter Reed Army Institute of Research) in double-distilled H2O.
In the f rst two experiments, primaquine was administered s.c. at 5, 10, 20,
and 25 h after each of the three immunizations with ␥-spz. In the third
experiment, two primaquine doses were administered 5 h apart after each
␥-spz immunization. ␥-spz-immune mice, ␥-spz-immune and primaquinetreated mice, as well as naive mice were challenged with 10,000 infectious
spz 1 wk after the last boost immunization and were rechallenged 6 mo
later.

IHMC
Mice were anesthetized, and the exposed livers were perfused via the hepatic portal vein with 10 ml of 0.05% solution of collagenase IV (SigmaAldrich, St. Louis, MO) in RPMI 1640 as described previously (5). The
livers were resected and incubated for 30 min at 37°C, after which the
livers were gently pressed through a Falcon cell strainer (BD Labware,
Franklin Lakes, NJ) and resuspended in HBSS (Life Technologies). The
bulky debris was removed, and the cell suspension was centrifuged at 1200
rpm for 10 min. The pellet was resuspended in HBSS, mixed with 33%
Percoll (Amersham Pharmacia Biotech, Uppsala, Sweden), and centrifuged
at 2000 rpm for 20 min. Isolated liver mononuclear cells were washed
twice in HBSS. Whereas the cell numbers from naive mice yielded on
average 2 ⫻ 106 lymphocytes/liver, the numbers of lymphocytes from
␥-spz immune mice ranged between 3 and 5 ⫻ 106 cells/liver.

Materials and Methods

Cytofluorometry

Animals

Cells were washed twice and resuspended in 0.2% NMS-PBS at 105 cells/
100 l. To block nonspecif c binding of mAb, cells were preincubated with
the Fc-block (anti-Fc␥RIII/II CD16/CD32 mAb; BD PharMingen, San Diego, CA) at 1 g/106 cells at 4°C for 30 min. After one wash, cells were
incubated with 0.5 g of the relevant mAb per 106 cells at 4°C for 30 min,
followed by two washes with cold PBS. Four-color f ow-cytometric analysis
was performed on a FACSCalibur (BD Biosciences, Mountain View, CA).
The following mAb were used: FITC-anti-CD45RB (553099), FITC-antiCD122 (553361), PE-anti-CD44 (553134), PerCP-anti-CD4 (553052), PerCPanti-CD8a (553036), and allophycocyanin-anti-CD62L (553152) (BD
PharMingen).

b

Female C57BL/6 (H-2 ) mice, purchased from The Jackson Laboratory
(Bar Harbor, ME), were used at 6 – 8 wk of age. IL-15 knockout (KO)
female mice (C57BL/6 background), purchased from Taconic Farms (Germantown, NY), were used at 5– 6 wk of age. Animals were housed and
handled according to institutional guidelines. Research was conducted in
compliance with the Animal Welfare Act and other federal statutes and
regulations relating to animals and experiments involving animals and adhered to principles stated in the Guide for the Care and Use of Laboratory
Animals (National Research Council publication, 1996 edition). All procedures were reviewed and approved by the Institute’s Animal Care and
Use Committee, and performed in a facility accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care International.

Preparation of spz
P. berghei (ANKA strain) spz were maintained by cyclical transmission in
mice and Anopheles stephensi mosquitoes. spz were dissected from the
salivary glands of mosquitoes 21 days after an infective blood meal, as
described previously (5). For immunization, spz were attenuated by exposure to 15,000 rad of radiation using a cesium-137 source (Mark I series;
JL Shepherd & Associates, San Fernando, CA), counted, and adjusted to a
given concentration in RPMI 1640 (Life Technologies, Grand Island, NY)
with 10% normal mouse serum (NMS). For challenge, spz were used im-

Positive selection of CD4⫹ and CD8⫹ T cells
The procedure for positive selection was done according to the manufacturer’s instructions (Miltenyi Biotec, Auburn, CA). Brief y, isolated IHMC
were washed twice with PBS-0.5% BSA buffer, and the cell pellet (107
cells) was resuspended in 90 l of buffer to which 10 l of MACS CD8␣
or CD4 MicroBeads 130-049-401 and 130-049-201, respectively, was
added, and the reaction mixture was incubated for 15 min at 6°C. Cells
were washed by adding 20⫻ labeling volume of PBS-0.5% BSA and 2 mM
EDTA, centrifuged at 300 ⫻ g for 10 min. The cell pellet was resuspended
in 500 l of buffer, and the cell suspension was applied to a positiveselection MS column. After the negative cells passed through, the column
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was rinsed three times with 500 l of buffer. The column was removed
from the separator, and 1 ml of buffer was added onto the column to f ush
out the positive fraction.

IFN-␥ secretion assay
The IFN-␥ determinations were performed using the secretion assay detection kit according to the manufacturer’s instructions (Miltenyi Biotec).
Brief y, IHMC were resuspended at 106cells/tube and washed twice with
cold PBS-0.5% BSA and 2 mM EDTA. Cells in 90 l of cold RPMI 1640
with 5% NMS plus 10 l of IFN-␥ capture reagent were incubated on ice
for 5 min and then diluted up to 105/ml with warm RPMI 1640 with 5%
NMS, transferred into f at-bottom 12-well plate, and incubated for 45 min
at 37°C. After two washes, cells were resuspended in 90 l of cold PBS
and incubated with 10 l of IFN-␥ detection reagent for 10 min at 4°C.
After the f nal two washes in PBS, cells were resuspended in 100 l of
freshly prepared 50 g/ml propidium iodide and analyzed by f ow cytometry. Data was analyzed by CellQuest software (BD Biosciences).

Statistical analysis
Data are shown as the mean ⫾ SD of cell numbers from at least three
separate experiments. Signif cance between data points was compared by
ANOVA and Tukey’s posttest. Values of p ⬍ 0.01 were considered
signif cant.

Results

Immunization with ␥-spz induces phenotypically distinct
subpopulations of liver CD8⫹ T cells
We have shown that repeated exposure to P. berghei ␥-spz induces
lasting protective immunity that is associated with activated intrahepatic memory CD8⫹CD44highCD45RBlow T cells (9). Other
studies have shown that distinct subsets of memory CD8⫹ T cells
could be revealed by the expression of migration ligands as well as
by functional activity. For example, effector memory T cells express CD62Llow and CCR5 and migrate to nonlymphoid tissue
where they engage in an effector function without additional activation; central memory T cells express CD62Lhigh and CCR7 and
home to T cell areas of secondary lymphoid organs, possibly to be
reactivated by future encounter with the Ag (22, 23). In the present
study, we extended the characterization of the intrahepatic memory

FIGURE 1. Immunization with P. berghei
␥-spz induces phenotypically distinct subsets of
liver CD8⫹ T cells. IHMC were isolated from livers of mice (two per group) 7 days after the tertiary
immunization with ␥-spz and analyzed by fourcolor FACS. Naive age-matched mice served as a
control. Lymphocytes were gated on a forwardside scatter plot, and gates were applied to identify
CD8⫹ T cells. CD8⫹ T cells were characterized
using anti-CD44, anti-CD45RB, and anti-CD62L
mAbs. Contour plots are shown, and percentages of
subsets of gated CD8⫹ T cells from a representative of three separate experiments are indicated: naive (A, C, and E); and ␥-spz-immunized mice (B,
D, and F). Numbers in the A and B quadrants represent percentages of CD8⫹ T cells. The numbers
in histograms represent percentages of CD62Llow
cells within the CD8⫹CD44highCD45RBlow T cell
subset (C and D) and the CD8⫹CD44highCD45RBhigh
T cell subset (E and F).

P. berghei-INDUCED LIVER CD8⫹ MEMORY T CELLS
CD8⫹ T cells to include both CD62L expression and IFN-␥ production
In the f rst set of experiments, we analyzed intrahepatic CD8⫹ T
cells to identify the subsets on the basis of their phenotypic markers following immunization with ␥-spz. Approximately 53% of
liver CD8⫹ T cells expressed CD44highCD45RBlow (Fig. 1B) and
nearly the entire (96%) subset was CD62Llow (Fig. 1D). In naive
mice, the CD44highCD45RBlow phenotype ranged between 10 and
27% of CD8⫹ T cells (data from a representative experiment is
shown in Fig. 1A). Among this subset, ⬃80% were CD62Llow
(Fig. 1C). Following tertiary immunization with ␥-spz, the
CD8⫹CD44highCD45RBhigh T cells declined 2-fold (compare Fig.
1, A and B), but a new fraction expressing CD62Llow emerged, and
then the CD62Llow/high phenotypes were represented in nearly
equal proportions (Fig. 1, E and F).
Thus, compartmentalization of intrahepatic CD8⫹CD44high T
cells into phenotypically distinct subsets was already evident in
naive mice. Following immunization with ␥-spz, the CD44high
CD45RBlowCD62Llow T cells became the dominant subset, and a
new, intermediate subset emerged that expressed a mixture of
CD62Lhigh/low. Presently, we do not know whether these subsets
represent stages of CD8⫹ T cell differentiation, expansion, or immigration from the peripheral immune organs to the liver. However, these observations imply that protective immunity induced
with ␥-spz depends on a network of T cells with distinct migratory
pattern, maturational diversity, and possibly distinct functions. For
example, the major CD8⫹CD44highCD45RBlowCD62Llow T cell subset might represent the effector memory pool, and the CD8⫹CD44high
CD45RBhighCD62Lhigh phenotype might represent a central memory
population, whereas the CD8⫹CD44highCD45RBhighCD62Llow might
indeed belong to an intermediate subset ready to be conscripted
into the effector population during reinfection.
Regarding liver CD4⫹ T cells, we conf rmed our previous observations that a large percentage, ranging from 28 to 55% of naive
CD4⫹ T cells, already expressed the memory phenotype (5).
Following the third immunization with ␥-spz, the memory subset
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transiently increased ⬃1.5-fold with nearly equally distributed
CD62Llow and CD62Lhigh phenotype (data not shown).
It has been demonstrated that immunization with LPS inf uences
the expression of phenotype and expansion of memory CD8⫹ T
cells (24). Therefore, as a control for nonspecif c expression of
memory phenotype CD8⫹ T cells, we examined memory markers
among the intrahepatic CD8⫹ and CD4⫹ T cells isolated 7 days
after tertiary immunization with ␥-irradiated salivary gland debris
dissected from noninfected mosquitoes. In comparison with intrahepatic CD8⫹ and CD4⫹ T cells from naive mice, LPS induced
only negligible shifts in the expression of the memory markers;
hence no changes were induced in the phenotypically distinct liver
T cell subsets (data not shown).
Effector memory CD8⫹CD44highCD45RBlowCD62Llow T cells
are maintained in the liver following challenge with
infectious spz
In the next set of experiments, we asked whether the arrangement
of activated memory CD8⫹ T cell subsets persisted in livers of
␥-spz-immune mice following spz challenge. For comparison, we
analyzed liver CD4⫹ and CD8⫹ T cells from naive, ␥-spz-immune
(after tertiary immunization), and ␥-spz-immune/challenged mice.
At preimmunity (naive), the CD8⫹CD44highCD45RBlowCD62Llow T
cells ranged between 50 and 100 ⫻ 103 cells/liver; however, this
subset rose to nearly 500 ⫻ 103 T cells following tertiary immunization with ␥-spz (Fig. 2A). Following spz challenge, the subset increased 4-fold, reaching 2000 ⫻ 103 cells/liver, thus representing between 45 and 75% of total liver CD8⫹ T cells (Fig. 2, A and E); most
importantly, however, effector memory T cells persisted for up to
28 days, and the level was ⬃10-fold higher that at preimmunity.
By contrast, the most pronounced increase (2-fold) of the
CD4⫹CD44highCD45RBlowCD62Llow T cells occurred on day 14
after the challenge (750 ⫻ 103 cells/liver), but the subset declined
to the preimmune level at day 28 (300 ⫻ 103 cells/liver) (Fig. 2A).
Upon closer examination of the distribution of CD8⫹ T cells
into CD44highCD45RBlow (effector memory) and CD44high
CD45RBhigh (central memory) T cell subsets under conditions of
immunization and challenge (Fig. 2, B–F), it became clear that the
central memory (CD44highCD45RBhigh) CD8⫹ T cells expanded
following priming with ␥-spz (from 39 to 57%), whereas the effector T cells required three doses of ␥-spz for the expansion to
occur (from 27 to 50%), and they continued to expand (up to 75%)
following the challenge. Moreover, the effector memory CD8⫹ T
cells remained elevated (67%) even 30 days after the challenge,
whereas the central memory T cells decreased 2-fold in comparison with preimmunity. The corresponding CD4⫹ T cell phenotype
remained unchanged (data not shown). Although these observations do not provide direct evidence that Ag exposure induces
central memory T cells to differentiate into effector memory T
cells, they nonetheless suggest the possibility of a propinquous
relationship between these two memory CD8⫹ T cells subsets,
which we are currently investigating.
Only effector memory CD8⫹ (CD44highCD45RBlow) T cells
responded swiftly by producing IFN-␥
It has been demonstrated previously that functional differences can
be discerned among separate subsets of memory CD8⫹ T cells (23,
25, 26). Accordingly, we hypothesized that only the effector memory T cells would produce mediators, such as IFN-␥, that have
been associated with protection against malaria (27, 28). To avoid
detection of IFN-␥ responses from cells that might have been induced
nonspecif cally during immunization with ␥-spz (24), we examined
both the CD44highCD45RBlow and CD44highCD45RBhighCD8⫹ T
cells for IFN-␥ production 1 mo after the last boost immunization

FIGURE 2. Effector memory CD8⫹ T cells persist in the liver after spz
challenge. A, IHMC were isolated from mouse livers (two per group) 7 days
after tertiary immunization with ␥-spz and at specif ed times (days) after spz
challenge of ␥-spz-immune mice. Naive mice served as a control. Four-color
FACS analyses were performed on liver T cells for CD8, CD4, CD44,
CD45RB, and CD62L with gates placed as described in Fig. 1. Results expressed as the mean of cell numbers ⫾ SD from three separate experiments
show effector memory (CD44highCD45RBlowCD62Llow) CD8⫹ T cells (䡺)
and CD4⫹ T cells (f) per liver; p ⬍ 0.01, as determined by ANOVA and
Tukey’s posttest; p ⬍ 0.01 between naive CD8⫹ T cells and CD8⫹ T cells
from tertiary immunization; and p ⬍ 0.01 between naive CD8⫹ T cells and
CD8⫹ T cells from 28 days after the challenge. B–F, Results are shown as
contour plots of effector and central memory liver CD8⫹ T cells subsets isolated from the livers of the following groups of mice at the indicated time
points: naive (B), ␥-spz primed (C), ␥-spz immunized three times (D), and
␥-spz immune and challenged (E and F). Results showing percentage of liver
CD8⫹ T cells expressing effector memory and central memory phenotype are
representative of three separately performed experiments.
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with ␥-spz (0 h) and at the indicated time points (hours and days) after
the challenge. We performed an ex vivo cytokine capture assay using
enriched (⬎95%) liver CD8⫹ T cells and CD4⫹ T cells, and the
responses are expressed as the number of IFN-␥-producing cells/106
IHMC. For CD8⫹CD44highCD45RBlow T cells, the response rose
from 2000 1 mo after the last immunization with ␥-spz to 8000 at 1 h
following spz challenge, and the elevated level of reactivity persisted
for 12 h after the challenge (Fig. 3A). Subsequent analyses revealed a
peak reactivity (30,000) 7 days after the challenge, and a decline to
⬃15,000 on days 14 and 28 (Fig. 3B).
The reactivity of the central memory (CD44highCD45RBhigh) T
cells differed sharply from that of the effector memory CD8⫹ T
cells. Before challenge (0 h), we measured only 500 IFN-␥-producing cells. The response increased slightly following spz challenge with a peak reactivity of ⬃5000 at 6 h after the challenge.
However, at 12 h, the response declined to preimmune level, at

P. berghei-INDUCED LIVER CD8⫹ MEMORY T CELLS
which it remained for the duration of the analyses (28 days). Because the distinction in the functional activity between the two
subsets of CD8⫹CD44high T cells was marked not only by their
celerity but also by the magnitude as well as the duration of the
response, these observations provide evidence that only the effector memory CD8⫹CD44highCD45RBlow T cells persisted to be
rapidly recalled into an effector mode even 1 mo after the last
immunization with ␥-spz.
CD8⫹CD44highCD45RBlow T cells isolated from livers of naive
mice showed negligible responses that ranged between 100 and
200 IFN-␥-producing cells. Immediately following the infection,
the CD8⫹CD44highCD45RBlow T cells remained indolent IFN-␥
producers, but at 12 h, the response rose to ⬃6000 IFN-␥-producing cells. In contrast to the declining responses observed among
␥-spz-immune and -challenged mice, the IFN-␥ responses of the

FIGURE 3. Secretion of IFN-␥ by liver memory CD8⫹ and CD4⫹ T cells. IHMC were isolated at the indicated times from the following groups of mice
(three mice per group): naive, ␥-spz immune, and ␥-spz immune and challenged. CD8⫹ and CD4⫹ T cells were enriched by magnetic separation, and
CD45RB and CD44 T cells subsets were identif ed, as described in Fig. 1, and analyzed for the production of IFN-␥ by cytokine secretion assay (see
Materials and Methods). A and B, Results from a representative of two experiments are presented as the number of IFN-␥-secreting cells/106 liver IHMC
at the indicated time points in hours (A) and in days (B) following challenge by effector memory (CD44highCD45RBlow) CD8⫹ T cells from ␥-spz-immune
mice (solid line, 䡺); central memory (CD44highCD45RBhigh) T cells from ␥-spz-immune mice (solid line, f), and effector memory CD8⫹ T cells from naive
mice (dotted line, 䡺). C and D, IFN-␥ secretion by CD4⫹ T cells at the indicated time points following challenge: in hours (C) and in days (D) by effector
memory T cells from ␥-spz-immune mice (solid line, E) and effector memory T cells from naive mice (dotted line, E).
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infected control mice rose to 10,000 IFN-␥-producing cells during
the following 2 wk. This uncontrolled inf ammatory response is
presumed to have been associated with parasitemia and immunopathology of malaria infection.
In contrast to CD8⫹ T cells, both naive and ␥-spz-immune
CD4⫹CD44highCD45RBlow cells secreted IFN-␥ at nearly comparable levels during the early time points (hours) after infection.
However, although the responses abated over time in protected
mice, they rose in infected control mice to a remarkable level
(40,000 IFN-␥-producing cells/106 IHMC). Hence, it appears that,
although the protective component of the IFN-␥ response stems
from CD8⫹ T cells, IFN-␥-responding CD4⫹ T cells are associated with the pathology caused by parasitemia.
Effector memory T cells producing IFN-␥ persisted in the liver
for ⬃1 year in ␥-spz-immune mice
In the next experiment, we asked whether the effector memory T
cells producing IFN-␥ persisted in the livers beyond 1 mo after the
challenge. A group of mice immunized three times with ␥-spz was
challenged and then rested for ⬃10 mo. Upon rechallenge, we
observed 100% protection (data not shown). Moreover, examination of the liver CD8⫹ T cells revealed persistence of the effector
memory phenotype (54%) (Fig. 4B). Analyses of liver lymphocytes from age-matched naive control mice showed that effector
memory phenotype CD8⫹CD44highCD45RBlow T cells accumulated in the livers of older mice, and their numbers appeared indistinguishable (40%) from the effector memory phenotype CD8⫹
T cells found in ␥-spz-immune/challenged mice (Fig. 4A). However, IFN-␥ responses differed sharply between the effector memory CD8⫹ T cells from naive and ␥-spz-protected mice. In naive
(Fig. 4C) mice, only 7% of memory phenotype CD8⫹ T cells
produced IFN-␥, whereas in protected mice, ⬃20% of CD8⫹
CD44highCD45RBlow T cells were IFN-␥ producers (Fig. 4D) at 10
mo after the challenge.
Analyses of effector and central memory CD8⫹ T cell subsets
for the production of IFN-␥ revealed similar results to those observed earlier, after the challenge: only the effector memory CD8⫹
T cells responded rapidly, and within 6 h after rechallenge, the
number of IFN-␥-producing cells rose from 2500 to 8000/106
IHMC. The central memory CD8⫹ T cells responded with a delay,
and the magnitude of response was considerably lower (Fig. 4E).
Age-matched infectivity control mice showed a hugely delayed
reactivity, which at the initial time points was very low. Interestingly, however, we observed that, during a challenge 10 mo earlier, the effector memory T cells had a swifter IFN-␥ reactivity,
which occurred 1 h after the challenge.
Ag depot in the liver is necessary for maintenance of
CD8⫹CD44highCD45RBlowCD62Llow T cells
According to one of two rival hypotheses, periodic exposure to Ag
is necessary for the maintenance of long-term memory T cells (29,
30). An alternative view proposes that the memory pool consists of
long-lived T cells capable of surviving without Ag stimulation (1,
31). In a study by Scheller and Azad (21), long-term protection
against P. berghei malaria induced by immunization with ␥-spz
could be abrogated by primaquine, if the drug is administered during priming and boosting with ␥-spz. Primaquine disrupts the developing liver schizonts and thus prevents the accumulation of
plasmodia-derived Ags in the liver. Therefore, we asked whether,
coincidental with primaquine-mediated loss of protection, we
could detect a reduction of either the central or effector memory
liver CD8⫹ T cells. Importantly, selective Ag sensitivity of one of

FIGURE 4. IFN-␥-secreting effector memory liver CD8⫹ T cells persist
during protracted protection. IHMC were isolated from a group of mice
(two mice per group) 10 mo after ␥-spz immunization and challenge. Agematched mice were used as a control. IFN-␥ was detected by cytokine
secretion assay, as described in Fig. 3. CD8⫹ T cells were enriched, and
CD44⫹CD45RBlow T cells were identif ed by FACS, as described in Fig.
1. Results from a representative of two separate experiments show CD8⫹
T cells from naive mice (A and C) and ␥-spz-immune and -challenged mice
(B and D). The numbers in quadrants (A and B) represent the percentage of
CD8⫹ T cells. The numbers in histograms, normalized to isotype controls,
represent the percentage of IFN-␥-secreting cells within CD8⫹CD44high
CD45RBlow (effector memory) T cells (C) and CD8⫹CD44highCD45RBhigh
(central memory) T cells (D). E, Kinetics of IFN-␥ secretion by CD8⫹ T
cells isolated from ␥-spz-immunized (䉫, E) and naive control (䉬, F) mice
after challenge. The number of IFN-␥-secreting effector memory (䉫, 䉬)
and central memory (E, F) per 106 IHMC was determined for each individual mouse (n ⫽ 3) at the indicated time points (hours) following spz
challenge and is presented as the mean ⫾ SD. The 0 h represents IFN-␥
response detected 10 mo after the f rst challenge (pre-rechallenge). A value
of p ⬍ 0.01 was determined by ANOVA plus Tukey’s posttest for all time
points between responses elicited from the central and effector memory
CD8⫹ T cells.

the two subsets of liver memory CD8⫹ T cells would support our
view that each set requires a distinct mechanism for its persistence.
We performed three separate experiments with two groups of
5–10 mice/group. Each group was immunized with three weekly
doses of ␥-spz, and one of the two groups was treated with primaquine during immunization. Upon spz challenge, both groups of
mice remained fully protected. As expected, naive control mice
became parasitemic (data not shown). Upon a rechallenge 5 mo
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later, the ␥-spz-immune mice remained fully protected; however,
40 – 60% of the primaquine-treated mice became parasitemic, as
did 100% of the control mice (data not shown).
In the f rst two experiments, we analyzed only the persistence of
liver CD8⫹CD45RBlow T cells. In comparison to ␥-spz-immune
mice that preserved the effector memory phenotype of CD8⫹ T
cells, primaquine-treated mice that became parasitemic clearly had
a decreased level of the analogous memory T cells as indicated by
the shift in the expression of CD45RB (Fig. 5A). Mice that maintained protective immunity despite primaquine treatment behaved
like the untreated, ␥-spz-immune controls and showed no changes
in the memory CD8⫹ T cells (Fig. 5B).
In the third experiment, we extended the analyses of the CD8⫹
T cells to include CD44highCD45RBlow and CD44highCD45RBhigh
phenotypes to determine whether the shift in the memory subsets
of CD8⫹ T cells was random or whether it selectively affected a
particular subset of the memory population. In comparison to effector memory CD8⫹ T cells found in nontreated mice at rechallenge, a ⬃5-fold reduction was observed among the liver effector
memory CD8⫹CD44highCD45RBlow T cells in primaquine-treated
mice that became parasitemic upon rechallenge (compare 120 vs
25 ⫻ 103 cells) (Fig. 6A). This was not the case for cells from treated
mice that remained protected, because that reduction was much
smaller in comparison with nontreated rechallenged mice. More signif cantly, the central memory CD8⫹CD44highCD45RBhigh T cells
remained unchanged in both groups (Fig. 6B). Identical cytof uorometric analyses of CD4⫹ lymphocytes revealed no differences in populations among all groups of mice (data not shown). Although additional experiments demonstrating a reduction of P. berghei Ags in the
liver as well as Ag specif city of the responding CD8⫹ T cells will be
needed for the conf rmation of these results, it is clear that, coincidental with the loss of protective immunity, there was a signif cant
reduction in the effector memory but not the central memory subpopulations of liver CD8⫹ T cells.

P. berghei-INDUCED LIVER CD8⫹ MEMORY T CELLS
Only central memory CD8⫹ T cells express CD122high (IL-15R)
Recently, it has been shown that IL-15 provides a signal necessary
for the survival of long-term memory CD8⫹ T cells, whereas IL-2
stimulates both the initial expansion and subsequent contraction of
T lymphocytes (32–35). This has been demonstrated in viral and
bacterial model systems, in which a slow cellular division in response to IL-15 maintains memory CD8⫹ T cells (36). Determination of CD122, the ␤-chain shared by IL-2R and IL-15R, expressed on various subtypes of liver lymphocytes from ␥-spzimmune mice (data not shown) conf rmed previous report(s) (37)
that CD4⫹ T cells were CD122neg. We have observed (N. Steers,
manuscript in preparation) that immunization with ␥-spz caused
up-regulation of IL-15 mRNA in Kupffer cells, but not in cells
isolated from spleens of ␥-spz-immune mice. Therefore, we asked
whether the presence of IL-15 in the liver might be involved in the
maintenance of local CD8⫹ T cells. We approached this investigation by determining whether the expression of CD122 might be
up-regulated on CD8⫹CD44highCD45RBlow (effector memory) as
well as CD8⫹CD44highCD45RBhigh (central memory) T cells as a
consequence of ␥-spz immunization and challenge. Although both
subsets expressed CD122, to our surprise, the density of CD122
expression on the central memory phenotype was much higher,
and thus, this subset was designated as CD44highCD45RBhigh
CD122high (Fig. 7). Twice as many central memory T cells expressed CD122high compared with the effector memory T cells.
This ratio of CD8⫹CD44highCD45RBhighCD122high to CD8⫹
CD44highCD45RBlowCD122low T cells was maintained for 14
days following spz challenge of ␥-spz-immune mice (data not
shown). Although presently we have no direct evidence that IL-15
is involved in the maintenance of liver CD8⫹CD44high T cells, the
difference in the expression of IL-15R indicates that IL-15 could
indeed exert distinct regulatory processes on the two sets of liver
CD8⫹CD44high T cells. Further conf rmatory evidence is needed

FIGURE 5. Primaquine causes a decline of memory CD8⫹CD45RBlow T cells. Following priming and each boost immunization with ␥-spz, a group of
f ve mice received primaquine (60 mg/kg) (see Materials and Methods). The mice were challenged 7 days after last immunization with ␥-spz and then
rechallenged 6 mo later. A group of f ve mice that were immunized with ␥-spz, challenged, and rechallenged was used as a control. Parasitemia was
determined by thin blood smears. IHMC were isolated from livers 9 (A) and 18 (B) days after rechallenge. Liver CD8⫹CD45RBlow T cells were identif ed
by two-color FACS as described in Fig. 1. Results in A show CD8⫹CD45RBlow T cells from ␥-spz-immune control mice that were protected at challenge
and rechallenge (f lled histogram) and ␥-spz-immune, primaquine-treated mice that were not protected upon rechallenge (bold gray line). Results in B show
CD8⫹CD45RBlow T cells from ␥-spz-immune control mice that were protected at challenge and rechallenge (f lled histogram) and ␥-spz-immune,
primaquine-treated mice that were protected upon rechallenge (bold gray line). The results are representative of two separately performed experiments (n ⫽ 20).
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FIGURE 7. Only the central memory CD8⫹ T cell subset expresses
high density CD122; hence CD44highCD45RBhigh cells are IL-15 dependent. IHMC were isolated from the livers of mice (two per group) 7 days
after tertiary immunization with ␥-spz. Subsets of CD8⫹ T cells were identif ed as described in Fig. 1, and the expression of CD122 was analyzed by
a four-color FACS. Results, representative of one of four separate experiments, show the expression of CD122 by central memory
(CD44highCD45RBhigh) CD8⫹ T cells (bold solid line) and effector memory (CD44highCD45RBlow) CD8⫹ T cells (thin solid line). The dotted line
represents isotype control.

FIGURE 6. Primaquine treatment selectively affects the effector memory (CD44highCD45RBlow) CD8⫹ T cells in the liver. A group of 10 ␥-spzimmune mice was treated with primaquine and challenged 7 days after last
immunization with ␥-spz and rechallenged 6 mo later (see Fig. 5 and Materials and Methods). A group of f ve mice was immunized with ␥-spz,
challenged, and rechallenged, and these mice served as a positive control.
IHMC were isolated from the livers of individual mice, and memory
CD8⫹CD44highCD45RBlow T cells (effector) and CD8⫹CD44highCD45RBhigh
T cells (central) were identif ed by four-color FACS as described in Fig. 1.
Results show effector memory (A) and central memory (B) CD8⫹ T cells per
106 IHMC derived from ␥-spz-immune, not treated controls (f), ␥-spz-immune, primaquine-treated, protected mice (䡺), and ␥-spz-immune, primaquine-treated, not protected mice (o). Combined results from two separately
performed experiments are expressed as the mean of cell numbers ⫾ SD. A
value of p ⬍ 0.01 was determined by ANOVA plus Tukey’s posttest.

to validate the effects of IL-15 on the maturation/maintenance of
liver memory T cells; nonetheless, these results demonstrated that
CD122low/high expression is a distinguishing feature of intrahepatic
memory CD8⫹ T cell subsets. Data from a recently published
study (3) also strongly imply that only CD8⫹CD44highCD122high
T cells are dependent on IL-15.
Even if IL-15 selectively affects the maintenance of the central
memory CD8⫹ T cells in the liver, by extension it will also affect
the effector memory sets, providing that the latter stems from the
differentiation of the former memory CD8⫹ T cells in response to
immunization with ␥-spz and challenge. We compared the expression of CD122 on central and effector liver memory CD8⫹ T cells
in naive mice (Fig. 8). On the basis of our observations, it appears
that, indeed, even in naive mice, the liver central memory CD8⫹ T
cell subset expressed CD122high. A comparison of the two CD8⫹

T cell sets derived from the livers of wild-type and IL-15 KO mice
showed that the numbers of both the central and the effector CD8⫹
T cells were markedly reduced in the IL-15 KO mice (Table 1);
however, only the central memory CD8⫹ T cells in the IL-15 KO
mice showed a reduced expression of CD122 (Fig. 8B). Interestingly, such differences between the central and effector memory
CD8⫹ T cell subsets were not observed among splenic CD8⫹ T
cells. The enhanced sensitivity of the central memory CD8⫹ T
cells to the reduced levels of IL-15 suggests that this subset preferentially expands upon exposure to elevated levels of IL-15 in the
liver. It also implies that an optimal protective response requires
the compartmentalization of CD8⫹ T cells, with each subset performing not only a unique role but also relying on distinct regulatory mechanisms.

Discussion

MHC class I-restricted CD8⫹ T cells that produce IFN-␥ are considered a key effector mechanism in protection induced by P.
berghei (28, 38) and Plasmodium yoelii (27, 4) ␥-spz against experimental infection. Protection induced by this process is longlived and associated with activated intrahepatic memory CD8⫹ T
cells (5). On the basis of the IFN-␥ response and cell surface markers indicative of either activation (CD44, CD45RB) or migration
(CD62L), we demonstrate that intrahepatic memory CD8⫹ T cells
generated by immunization with P. berghei ␥-spz consisted of at
least two distinct subsets: the dominant, IFN-␥-producing
CD44highCD45RBlowCD62Llow phenotype, hence effector memory set; and the indolent IFN-␥-producing CD44highCD45RBhigh
CD62Llow/high phenotype, hence central memory set. We propose
that these functionally and phenotypically unique subsets of liver
memory CD8⫹ T cells form an interactive network involving different phases of cell activation and differentiation, the balance of
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FIGURE 8. IL-15 KO mice express low density
CD122 on central memory CD8⫹ T lymphocytes.
IHMC were isolated from the livers of naive wild-type
and IL-15 KO mice (two per group). Subsets of CD8⫹
T cells were identif ed, as described in Fig. 1, and
analyzed for the expression of CD122 with mAb reactive with the IL-15R ␤-chain. Representative results
from one of two experiments show the expression of
CD122 on effector (A) and central memory (B) CD8⫹
T cells isolated from IHMC of wild-type (WT) (bold
line) and IL-15 KO (thin line) mice.

which is regulated by the local availability of specif c LSA and
IL-15. Whereas the effector memory CD8⫹ T cells were primarily
sensitive to the availability of LSA, the central memory CD8⫹ T
cells were dependent on the provision of IL-15.
The copresence of distinct subsets within the intrahepatic memory CD8⫹ T cell pool in mice protected against malaria is consistent with an earlier view that virally induced memory CD8⫹ T
cells are organized into subsets based on distinct functional activities and the maturation/activation status (25, 26). Similar to the
rapid lysis mediated by inf uenza- and Sendai-specif c effector
memory CD8⫹ T cells (39), intrahepatic ␥-spz-immune effector
memory CD8⫹ T cells produced a copious amount of IFN-␥ within
1– 6 h after spz infection. Over time, after the challenge, the pool
of effector memory T cells contracted, and the IFN-␥ response
became reduced, but the population of IFN-␥-producing memory
cells persisted, exceeding by ⬃3-fold those found in naive mice.
IFN-␥-producing effector memory CD8⫹ T cells were also observed in the livers of long-term ␥-spz-immune mice (10 mo) that
maintained protracted protection against a rechallenge. This contrasted signif cantly with the effector memory phenotype CD8⫹ T
cells that accumulated in the livers of age-matched naive controls,
because these cells produced comparatively low levels of IFN-␥.
Hence, the long-lived intrahepatic effector memory CD8⫹ T cells
that were recalled to rapidly produce IFN-␥, play a decisive role in
protection induced with P. berghei ␥-spz. It could be argued that
liver CD8⫹ T cells from naive mice exposed to infectious spz were
also high IFN-␥ producers, yet these mice failed to be protected.
The marked delay in the IFN-␥ response most likely contributed in
part to the onset of parasitemia as an absence of an inf ammatory
response might have permitted uncontrolled proliferation as well
as development of the parasites to occur.
By contrast to the effector (CD44highD45RBlowCD62Llow)
memory CD8⫹ T cells, the IFN-␥ reactivity of the central
(CD44highD45RBhighCD62Llow/high) memory population exhibited
a lag period, and the responses were considerably lower and relatively short-lived. Therefore, these cells did not appear to be diTable I. Both effector and central memory phenotype liver CD8⫹ T
cells are reduced in IL-15 KO micea
Mice

Effector Memory (%)

Central Memory (%)

Wild type
IL-15 KO

27
5

35
7

a
IHMC were isolated from livers of naive wild-type and IL-15 KO mice and
stained with anti-CD8, anti-CD44, and anti-CD45RB mAbs. Subsets of CD8⫹ T cells
were identif ed as described in Fig. 1. The results shown are from one of two representative experiments. The numbers indicate percentages of liver CD8⫹ T cells.

rectly involved in the elimination of the parasite. Instead, by acquiring the CD122high phenotype, the central memory CD8⫹ T
cells most likely engaged in a proliferation, which qualif ed them
to function as a reservoir to maintain the size of memory CD8⫹ T
cell pools. Indeed, recent evidence from studies of Ag-specif c
memory CD8⫹ T cells present in the lung airways of mice infected
with Sendai virus demonstrate the copresence of two memory
CD8⫹ T cell subsets, one of which is maintained in the lung by
homeostatic proliferation (40). The maintenance of memory pools
is one of the prerequisites of a memory T cell response, because
attrition, particularly of the effector CD8⫹ T cells, is inevitable
during any infection (41).
Memory CD8⫹CD44high T cells segregated into two distinct
populations on the basis of the IFN-␥ response and CD122 expression: the central memory CD44highCD45RBhigh T cells were
CD122high, whereas effector memory CD44highCD45RBlow T cells
did not differ from naive and effector cells in that they were
CD122low. Judge et al. (3) have recently made similar observations
that CD8⫹CD44highCD122high T cells are highly dependent on
IL-15 for proliferation and survival. Moreover, proportionally,
there were at least twice as many central as effector memory CD8⫹
T cells expressing CD122. It is not unreasonable to presume that
the effector memory T cells, being eff cient IFN-␥ producers, were
refractory to the proliferative process, hence their CD122low phenotype. Therefore, the observation that ␥-spz immune mice contained proportionally more CD122high central memory CD8⫹ T
cells, which were highly dependent on IL-15, as shown in the
IL-15 KO mice, fully supports the view that the role of this subset
is distinct from that of the effector memory T cells.
Conscription of central memory CD8⫹ T cells into the effector
memory pool could be a continuous, albeit slow, process occurring
in the liver as a result of an increased Ag load following repeated
immunizations with ␥-spz. The process could also occur during
infection, when large numbers of effector memory CD8⫹ T cells
would be most needed to combat the parasite. In either case, the
cells in the central memory CD8⫹CD44highCD45RBhighCD122high
T cell pool would expand under the inf uence of IL-15 up-regulated by ␥-spz immunization. Upon encounter with specif c Ags
from the liver repository, the central memory CD8⫹ T cells would
be driven to differentiate into the CD44highCD45RBlowCD122low
phenotype that is easily triggered by infectious spz to produce
IFN-␥. The effector memory T cells might, in addition, proliferate
to Ag, a notion that is consistent with the recent f ndings showing
Ag-specif c proliferation of terminally differentiated memory
CD8⫹CD45RA⫹CD27⫺ T cells (42). Regardless of which of the
two mechanisms operates in the liver to preserve memory CD8⫹ T
cells, each relies on Ag for the maintenance of intrahepatic effector
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memory CD8⫹ T cells in mice protected by immunization with
␥-spz.
There are several, often opposing, views regarding the need for
Ag for the persistence of memory T cells. We suggest that lasting
protective immunity in the ␥-spz model depends upon a depot of
Ag in the liver, but this requirement for Ag could be delineated
only through the analysis of very specif c circuits of interacting T
cell subsets engaged in protracted protection. This process typically requires many different phases of T cell memory development, each with unique cellular and molecular requirements. For
example, loss of protection in mice treated with primaquine, a drug
that disrupts intrahepatic development of the parasite and hence
blocks the maintenance of protective immunity (21), was accompanied by a 5-fold decrease in the number of intrahepatic effector
memory CD8⫹ T cells. Signif cantly, the central memory subset
was not affected. We assume that disruption of the intrahepaticstage parasite development prevented the formation of a local Ag
depot, which impeded the conscription or differentiation of central
into effector memory CD8⫹ T cells. Although the majority of results from other studies convincingly argue against the need for Ag
to maintain long-lived memory CD8⫹ T cells, we suggest that Ag
requirements might be quite different in instances in which a parasite exhibits tropism to an immune-privileged organ, such as the
liver in plasmodia infection. It is possible that pathogens such as
plasmodia spz establish an Ag repository in the liver parenchyma
or in Kupffer cells. The chronic Ag depot may modify the local,
normally immunosuppressive environment (9) to create conditions
favorable for the maintenance of the activated memory T cells. In
some instances, the liver Ag repository may be suff cient to set
apart the local activated liver memory T cells from those found in
the spleen or lymph nodes.
Our hypothesis provides a partial explanation for the need of
intermittent boost immunizations with ␥-spz to maintain protective
immunity induced in humans by immunization with P. falciparum
␥-spz (16, 43). Moreover, it is supported by recent evidence from
our laboratory that memory CD4⫹ T cells that characterize longlasting protection induced in humans by P. falciparum ␥-spz (44)
are also organized into an interactive network of subsets, each
displaying a unique phase of maturation/differentiation, as demonstrated by phenotypic and functional features.
More recent evidence based on chemokines and migration
markers (22, 23) also support the organization of memory T cells
into a central (CD62LhighCCR7) phenotype that localizes primarily to lymph nodes and an effector set, which, upon acquiring the
CD62Llow or CCR7 phenotype, migrates from immune organs toward the site of inf ammation in a nonlymphoid tissue. The intrahepatic memory CD8⫹ T cells surprisingly appear to contain both
subsets. Although it is likely that both sets emigrated from the
spleen and lymph nodes to the site of inf ammation in the liver, it
is also possible that both activation and maintenance of plasmodia
Ag-specif c CD8⫹ T cells occurred locally in the liver. The local
availability of highly active effector memory T cells in the liver
clearly presents an advantageous situation for the host, because
these cells are poised to mount a rapid defense against the parasite.
In summary, the success of protection induced by ␥-spz depends
on the long-lived intrahepatic memory CD8⫹ T cells, which reside
in distinct subpopulations as central and effector memory T cells.
Although the effector memory T cells are maintained by the Agdriven conscription of the central memory T cells, the latter, representing a very broad spectrum of Ag-specif c T cells, is maintained by IL-15. This arrangement, based on a conscription process
from the central to the effector memory CD8⫹ T cell phenotype,
ensure the availability of Ag-specif c T cells, should they be required to combat an infection. The dependence on specif c Ag
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essentially controls the balance between the two phenotypes, and
the differential expression of IL-15R prevents the effector memory
CD8⫹ T cells from becoming activated in the event of sporadic
coinfections. However, it is the activated status of the intrahepatic
memory CD8⫹ T cells that really distinguishes them from the
memory CD8⫹ T cells in the spleen and lymph node, because it
represents the sentinel of a local, organ-specif c infection.
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